Recent Episodes
CAR T-cell Therapy in 2022: What You Need to Know Part II
Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
Everything You Need to Know About Cutaneous T-cell Lymphoma
Francine Foss, MD and John A. Zic, MD, MMHC
A Deep Dive into Myelofibrosis
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Categories
- All Episodes (54)
- CAR T-cell Therapy (7)
- Clinical Trials (2)
- COVID-19 (7)
- General Treatment & Support (14)
- Genomics (2)
- Leukemia (11)
- Lymphoma (8)
- Minimal Residual Disease (MRD) (2)
- Myelodysplastic Syndromes (2)
- Myeloma & Amyloidosis (8)
- Myeloproliferative Neoplasms (2)
- Pediatric and AYA (7)
- Transplantation (1)
